Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Comfort Kunak Ogar"'
Autor:
Tamara Hafner, Andy Stergachis, Merana Mussá, Irénio Gaspar, Luisa Namburete, Tânia Vuyeya Sitoie, Aleny Couto, Jamal Mario Paulino, Abrao Lemos, Stefia Vilanculos, Comfort Kunak Ogar, Denylson Namburete, Eunice Dias Seni
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Introduction Dolutegravir-based antiretroviral therapy (ART) is increasingly being used as the preferred first-line regimen for the treatment of HIV in low-income and middle-income countries. The National Program for the Control of STI/HIV/AIDS in Mo
Externí odkaz:
https://doaj.org/article/6267e280f1404994be67bf9dfdbefd15
Autor:
Kazeem Adeola Oshikoya, Ibrahim Abayomi Ogunyinka, Comfort Kunak Ogar, Abiodun Abiola, Ali Ibrahim, Ibrahim Adekunle Oreagba
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 11 (2020)
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nigerian population. Here, we de
Externí odkaz:
https://doaj.org/article/0f2a25d1fa3949aa8e374e7b2145e98d
Autor:
Emmanuel C Amadi, Ibrahim A. Oreagba, Comfort Kunak Ogar, Daniel Yuah, Kazeem A Oshikoya, Ali Ibrahim, Mojisola Christianah Adeyeye, Abiodun Abiola
Publikováno v:
Pharmaceutical medicine. 33(2)
Adverse drug reactions (ADRs) are a source of concern in healthcare as they negatively affect patients. Serious adverse drug reactions (SADRs) have an even greater impact on patients and the system in terms of morbidity and financial burden. The esta
Autor:
Ali Ibrahim, Kemi Alonge, Yetunde Oni, Fatima Jajere, Ashega Ademulegun Kigbu-Adekunle, Comfort Kunak Ogar, Adeline Osakwe
Publikováno v:
Pharmaceutical Medicine. 32:131-141
Direct patient reporting (DPR) is a system where patients report suspected adverse drug reactions (ADRs) directly to competent bodies. Studies have shown the added advantages of DPR of ADRs. In August 2012, the National Pharmacovigilance Centre (NPC)
Autor:
Isah Ambrose, Olumide Ogundahunsi, Charles Mensah, Blessing Ukpabi, Olalekan A. Uthman, Alash'le Abimiku, Yohanna Kambai Avong, Patrick Dakum, Osman El-Tayeb, Adeline Osakwe, Oche Agbaji, Comfort Kunak Ogar, Yetunde Oni, Kamau Edward Mberu, Eunice Bosede Avong, Dennis Mordi, Saswata Dutt, Bolajoko Jatau, Victor Adekanmbi, Istifanus Usman, Ali Ibrahim, Ritmwa Gurumnaan, Gbenga A. Kayode, James Okuma, B. M. Afolabi, Helga Nosiri, Nanfwang Danat
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0200810 (2018)
PLoS ONE, Vol 13, Iss 8, p e0200810 (2018)
Background\ud \ud Adverse Drug Reactions (ADRs) are a major clinical and public health problem world-wide. The prompt reporting of suspected ADRs to regulatory authorities to activate drug safety surveillance and regulation appears to be the most pra
Autor:
Yetunde Oni, Kazeem A Oshikoya, Abiodun Adefurin, Comfort Kunak Ogar, Olufunsho Awodele, Ali Ibrahim, Ibrahim A. Oreagba
Publikováno v:
Pharmacology Research & Perspectives
Adverse drug reactions (ADRs) recorded in national pharmacovigilance databases in developed countries have been analyzed. However, adverse reactions to fluoroquinolones were observed globally despite their wide use and safety concerns. We provided in
Autor:
PU Bassi, Adeline Osakwe, Godwin N. Ntadom, Cassandra Elagbaje, Biyaya B. Nwankwo, S T Balogun, Ambrose O. Isah, Comfort Kunak Ogar
Publikováno v:
Pharmacology Research & Perspectives
Artemisinin‐based combination antimalarial therapy (ACTs), is still highly effective in uncomplicated falciparum malaria, however, there remain some concerns in relation to its safety and tolerability. Comorbid disease conditions may influence susc